investors aduro.com

Investor Relations Aduro Biotech

Aduro is a clinical-stage cancer immunotherapy company with three products currently in human trials. The companys lead candidate an immunotherapy regimen combining our proprietary CRS-207 with GVAX Pancreas is targeting metastatic pancreatic cancer and has received Breakthrough Therapy designation from the US Food and Drug Administration. August 14, 2015. August 10, 2015. Aduro Biotech Announces Second Quarter 2015 Financial Results. August 10, 2015. View all Press Releases. August 12, 2015.

OVERVIEW

The domain investors.aduro.com presently has an average traffic classification of zero (the smaller the more traffic). We have inspected zero pages within the web site investors.aduro.com and found forty websites associating themselves with investors.aduro.com.
Links to this site
40

INVESTORS.ADURO.COM TRAFFIC

The domain investors.aduro.com is seeing variant quantities of traffic all over the year.
Traffic for investors.aduro.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for investors.aduro.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for investors.aduro.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO DOMAIN

WHAT DOES INVESTORS.ADURO.COM LOOK LIKE?

Desktop Screenshot of investors.aduro.com Mobile Screenshot of investors.aduro.com Tablet Screenshot of investors.aduro.com

INVESTORS.ADURO.COM SERVER

I found that a single root page on investors.aduro.com took six hundred and fifty-six milliseconds to download. We could not detect a SSL certificate, so in conclusion our web crawlers consider this site not secure.
Load time
0.656 secs
SSL
NOT SECURE
Internet Protocol
128.177.96.16

HTML TITLE

Investor Relations Aduro Biotech

DESCRIPTION

Aduro is a clinical-stage cancer immunotherapy company with three products currently in human trials. The companys lead candidate an immunotherapy regimen combining our proprietary CRS-207 with GVAX Pancreas is targeting metastatic pancreatic cancer and has received Breakthrough Therapy designation from the US Food and Drug Administration. August 14, 2015. August 10, 2015. Aduro Biotech Announces Second Quarter 2015 Financial Results. August 10, 2015. View all Press Releases. August 12, 2015.

PARSED CONTENT

The domain has the following in the homepage, "Aduro is a clinical-stage cancer immunotherapy company with three products currently in human trials." We analyzed that the web site also stated " The companys lead candidate an immunotherapy regimen combining our proprietary CRS-207 with GVAX Pancreas is targeting metastatic pancreatic cancer and has received Breakthrough Therapy designation from the US Food and Drug Administration." It also stated " Aduro Biotech Announces Second Quarter 2015 Financial Results."

SEEK OTHER BUSINESSES

Blog de KataBest - KataBest-X3 - Skyrock.com

je le réaliserais pas . Amour et toujours ne riment plus ensemble maintenant . Les psychopathes ne trainent pas a tous les coins de rue Vous en êtes sur? M et N ne sont pas cotes a cotes pour rien . Vous me remercierez plus tard . Amour ne rime pas avec toujours. Amitié ne se marie pas avec respect . Moi je serais votre KataBest .

Blog de my-or-Gus - My Fic, My Gus - Skyrock.com

My Fic, My Gus. Abonne-toi à mon blog! AlOrs vOila, cOmme beaucOup en ce mOment je cOmmence une fic.